Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders

Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders

A focused in-house library of about 1000 compounds comprising various heterocyclic motifs in combination with structural fragments similar to β-phenylethylamine or tyramine was screened for the agonistic activity towards trace amine-associated receptor 1 (TAAR1). The screening yielded two closely re...

Full description

Bibliographic Details
Main Authors:	Mikhail Krasavin, Alexey Lukin, Ilya Sukhanov, Andrey S. Gerasimov, Savelii Kuvarzin, Evgeniya V. Efimova, Mariia Dorofeikova, Anna Nichugovskaya, Andrey Matveev, Kirill Onokhin, Konstantin Zakharov, Maxim Gureev, Raul R. Gainetdinov
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Biomolecules
Subjects:	schizophrenia trace amine-associated receptor 1 agonism 1,2,4-triazoles dopamine transporter knockout rats dopamine
Online Access:	https://www.mdpi.com/2218-273X/12/11/1650

Similar Items

Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
by: Savelii R. Kuvarzin, et al.
Published: (2023-07-01)

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
by: Ilya Sukhanov, et al.
Published: (2018-04-01)

Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-<i>N</i>-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders
by: Mikhail Krasavin, et al.
Published: (2022-09-01)

6-[2-(4-arylpiperazin-1-yl)ethyl]-4-halo-1,3-dihydro-2h-benzimidazole-2-thiones: Synthesis and pharmacological evaluation
by: Andrić Deana, et al.
Published: (2007-01-01)

6-[2-(4-Arylpiperazin-1-yl)ethyl]-4-halo-1,3-dihydro-2H-benzimidazole-2-thiones: synthesis and pharmacological evaluation
by: DEANA ANDRIC, et al.
Published: (2007-08-01)

Behavioral Effects of a Potential Novel TAAR1 Antagonist
by: Vincent M. Lam, et al.
Published: (2018-09-01)

Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma
by: Anastasia N. Vaganova, et al.
Published: (2022-01-01)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
by: Ilya S. Zhukov, et al.
Published: (2022-12-01)

Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D2 Receptor Ligand
by: Magda Kondej, et al.
Published: (2018-09-01)

(R)-4-[2-(Methylsulfanyl)pyrimidin-4-yl]-1-(tetrahydrofuran-3-yl)-1H-pyrazol-5-amine
by: Zhengyu Liu, et al.
Published: (2009-04-01)

4-(4-Fluorophenyl)-1-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amine
by: Stefan Laufer, et al.
Published: (2012-03-01)

Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors
by: Anna V. Glyakina, et al.
Published: (2021-12-01)

The Case for TAAR1 as a Modulator of Central Nervous System Function
by: Grazia Rutigliano, et al.
Published: (2018-01-01)

Crystal structure of tris[4-(naphthalen-1-yl)phenyl]amine
by: Masafumi Yano, et al.
Published: (2020-10-01)

The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
by: Anastasia N. Vaganova, et al.
Published: (2023-09-01)

4-tert-Butyl-5-(1H-1,2,4-triazol-1-yl)thiazol-2-amine
by: An-Yun Xie, et al.
Published: (2009-08-01)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
by: Stuart H. Isaacson, et al.
Published: (2023-01-01)

The Synthesis and Molecular Structure of 1-(3,4-Dihydroxyphenethyl)-3-hydroxy-2-methylpyridin-4(1H)-one Hydrochloride Methanol Solvate
by: Andreas Decken, et al.
Published: (2013-05-01)

Dibenzyl({1-[(4-methyl-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1H-1,2,3-triazol-4-yl}methyl)amine
by: Salaheddine Boukhssas, et al.
Published: (2017-06-01)

Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine
by: Michael D. Schwartz, et al.
Published: (2018-02-01)

Crystal structure of {(E)-4-[(1-allyl-1H-1,2,3-triazol-4-yl)methoxy]benzylidene}[2-(morpholin-4-yl)ethyl]amine
by: Sevim Türktekin Çelikesir, et al.
Published: (2014-09-01)

(R)-N-Methyl-4-[2-(methylsulfanyl)pyrimidin-4-yl]-1-(tetrahydrofuran-3-yl)-1H-pyrazol-5-amine
Published: (2009-03-01)

4-(4-Fluorophenyl)-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazol-5-amine
by: Bassam Abu Thaher, et al.
Published: (2012-09-01)

3-Pyridin-2-yl-1H-1,2,4-triazol-5-amine
by: Anton V. Dolzhenko, et al.
Published: (2009-01-01)

4-(3,4-Dihydro-&#946;-carbolin-1-yl)pyrimidin-2-amine
Published: (2009-03-01)

Synthesis and characterization of benzylidene- [1,3,4]thaidiazol -2-yl-amine
by: Al-Kaddimy H. A. Ahmed
Published: (2006-06-01)

5-[(2-Methyl-4-nitro-1H-imidazol-1-yl)methyl]-1,3,4-thiadiazol-2-amine
by: D. Revannasiddaiah, et al.
Published: (2013-12-01)

(2,4-Dichlorobenzylidene)[2-(1H-indol-3-yl)ethyl]amine
by: Suganya Murugan, et al.
Published: (2023-09-01)

Dimethyl[(E)-(2-nitromethylidene-1,3-dithiolan-4-yl)methyl]amine
by: Shuang-Hua Yang, et al.
Published: (2012-06-01)

Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward
by: Catherine F. Moore, et al.
Published: (2018-02-01)

Crystal structure and Hirshfeld surface analysis of the hydrochloride salt of 8-{4-[(6-phenylpyridin-3-yl)methyl]piperazin-1-yl}-3,4-dihydroquinolin-2(1H)-one
by: Nisar Ullah, et al.
Published: (2021-02-01)

Structural and functional evolution of the trace amine-associated receptors TAAR3, TAAR4 and TAAR5 in primates.
by: Claudia Stäubert, et al.
Published: (2010-06-01)

<i>N</i>,<i>N</i>-Bis(4′-(hexyloxy)-[1,1′-biphenyl]-4-yl)thiophen-2-amine
by: Timofey N. Chmovzh, et al.
Published: (2021-10-01)

Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease
by: Damiana Leo, et al.
Published: (2022-07-01)

The Signaling and Pharmacology of the Dopamine D1 Receptor
by: Jace Jones-Tabah, et al.
Published: (2022-01-01)

Unusual synthesis of 1-(4-fluorobenzyl)-N-(1-(1-(4-fluorobenzyl)-6-isopropoxy-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)-6-isopropoxy-1H-benzo[d]imidazol-2-amine
by: Amitabh Jha
Published: (2005-10-01)

N-[(E)-(5-Methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine
by: Zahid H. Chohan, et al.
Published: (2009-01-01)

5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine (tizanidine)
by: Peter John, et al.
Published: (2011-04-01)

N-[(Z)-(1-Methyl-1H-pyrrol-2-yl)methylidene]-1H-1,2,4-triazol-5-amine
by: Zahid H. Chohan, et al.
Published: (2009-01-01)

Nucleophilicity and solvent effects on the kinetics of 4-(pyren-1-yl)thiazol-2-amine interaction with 4,6-dinitrobenzofuroxan
by: Nizar El Guesmi, et al.
Published: (2020-02-01)